|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 2318 Mill Rd. Suite 800 |
Address2 |
|
City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3424-12
|
||||||||
|
6. House ID# 311000000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Amanda Schwartz |
Date | 10/23/2018 12:12:58 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 6836, the CLINICAL TREATMENT Act
H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017
Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)
Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amanda |
Schwartz |
|
|
|
Shelagh |
Foster |
|
|
|
Jennifer |
Brunelle |
|
|
|
Tyler |
Hanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2018 and FY 2019 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amanda |
Schwartz |
|
|
|
Shelagh |
Foster |
|
|
|
Jennifer |
Brunelle |
|
|
|
Tyler |
Hanson |
|
|
|
Kristin |
Palmer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R.1409 - Cancer Drug Parity Act of 2017
H.R.820/ S. 292 - Childhood Cancer STAR Act
H.R.1231/S. 456 - RACE for Children Act
H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act
H.R.878 - Right to Try Act of 2017
S.204 - Trickett Wendler Right to Try Act of 2017
H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017
Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation)
H.R. 2430 FDA Reauthorization Act
S. 934 FDA Reauthorization Act
H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA)
H.R. 2999Patient's Access to Treatment Act (PATA)
H.R. 1628Better Care Reconciliation Act (BCRA)
H.R. 1316Prescription Drug Pricing Transparency Act
H.R. 2077 Restoring Patients Voices Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amanda |
Schwartz |
|
|
|
Shelagh |
Foster |
|
|
|
Jennifer |
Brunelle |
|
|
|
Tyler |
Hanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
H.R.1136 FDA Deeming Authority Clarification Act of 2017
S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
H.R. 4273/S.2100 Tobacco to 21 Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amanda |
Schwartz |
|
|
|
Shelagh |
Foster |
|
|
|
Jennifer |
Brunelle |
|
|
|
Tyler |
Hanson |
|
|
|
Kristin |
Palmer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MIA
16. Specific lobbying issues
FASTR Act (Free Access to Science and Technology Research Act)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amanda |
Schwartz |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |